SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12802024
Source:
http://linkedlifedata.com/resource/pubmed/id/12802024
Search
Subject
(
80
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0013216
,
umls-concept:C0019829
,
umls-concept:C0205179
,
umls-concept:C0879265
,
umls-concept:C1442989
,
umls-concept:C1707455
pubmed:issue
24
pubmed:dateCreated
2003-6-12
pubmed:abstractText
Faced with unsatisfactory results of treatment for advanced Hodgkin's disease, we investigated three combinations of chemotherapy.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12802024
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12802024-12802021
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12802024-13679536
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0255562
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Bleomycin
,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide
,
http://linkedlifedata.com/resource/pubmed/chemical/Dacarbazine
,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin
,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide
,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisone
,
http://linkedlifedata.com/resource/pubmed/chemical/Procarbazine
,
http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine
,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1533-4406
pubmed:author
pubmed-author:DörkenBerndB
,
pubmed-author:DühmkeEckhardtE
,
pubmed-author:DiehlVolkerV
,
pubmed-author:FranklinJeremyJ
,
pubmed-author:German Hodgkin's Lymphoma Study Group
,
pubmed-author:HasencleverDirkD
,
pubmed-author:HerrmannRichardR
,
pubmed-author:LathanBerndB
,
pubmed-author:LoefflerMarkusM
,
pubmed-author:Müller-HermelinkHans-KonradHK
,
pubmed-author:PaulusUrsulaU
,
pubmed-author:PfreundschuhMichaelM
,
pubmed-author:TeschHansH
pubmed:copyrightInfo
Copyright 2003 Massachusetts Medical Society
pubmed:issnType
Electronic
pubmed:day
12
pubmed:volume
348
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2386-95
pubmed:dateRevised
2009-5-22
pubmed:meshHeading
pubmed-meshheading:12802024-Aged
,
pubmed-meshheading:12802024-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:12802024-Bleomycin
,
pubmed-meshheading:12802024-Combined Modality Therapy
,
pubmed-meshheading:12802024-Cyclophosphamide
,
pubmed-meshheading:12802024-Dacarbazine
,
pubmed-meshheading:12802024-Dose-Response Relationship, Drug
,
pubmed-meshheading:12802024-Doxorubicin
,
pubmed-meshheading:12802024-Etoposide
,
pubmed-meshheading:12802024-Female
,
pubmed-meshheading:12802024-Hodgkin Disease
,
pubmed-meshheading:12802024-Humans
,
pubmed-meshheading:12802024-Leukemia
,
pubmed-meshheading:12802024-Male
,
pubmed-meshheading:12802024-Middle Aged
,
pubmed-meshheading:12802024-Neoplasm Staging
,
pubmed-meshheading:12802024-Neoplasms, Second Primary
,
pubmed-meshheading:12802024-Prednisone
,
pubmed-meshheading:12802024-Procarbazine
,
pubmed-meshheading:12802024-Survival Analysis
,
pubmed-meshheading:12802024-Vinblastine
,
pubmed-meshheading:12802024-Vincristine
pubmed:year
2003
pubmed:articleTitle
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
pubmed:affiliation
First Department of Internal Medicine, University of Cologne, Cologne, Germany. v.diehl@uni-koeln.de
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study